DECELLULARIZED BIOMATERIAL FORM NON-MAMMALIAN TISSUE

(19)

(11)

EP 2 943 209 B8

(12)	CORRECTED EUROPEAN PATENT SPECIFICATION
	Note: Bibliography reflects the latest situation

(15)	Correction information:
	Corrected version no 1 (W1 B1)

(48)	Corrigendum issued on:
	07.04.2021 Bulletin 2021/14

(45)	Mention of the grant of the patent:
	24.02.2021 Bulletin 2021/08

(21)	Application number: 14737892.1

(22)	Date of filing: 09.01.2014

(51)

International Patent Classification (IPC):

A61K 35/65^(2015.01)
A61K 9/14^(2006.01)
A61L 27/38^(2006.01)
A61P 17/02^(2006.01)

A61K 9/10^(2006.01)
A61L 27/36^(2006.01)
A61L 27/52^(2006.01)

(86)	International application number:
	PCT/US2014/010890

(87)	International publication number:
	WO 2014/110269 (17.07.2014 Gazette 2014/29)

(54)	DECELLULARIZED BIOMATERIAL FORM NON-MAMMALIAN TISSUE DEZELLULARISIERTER BIOLOGISCHER STOFF AUS NICHT-SÄUGERGEWEBE MATÉRIEL BIOLOGIQUE DÉCELLULARISÉ ISSU DE TISSU NON MAMMIFÈRE

(84)	Designated Contracting States:
	AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30)

Priority:

09.01.2013 US 201361750555 P

(43)	Date of publication of application:
	18.11.2015 Bulletin 2015/47

(73)	Proprietor: NeXtGen Biologics, Inc.
	Alachua, FL 32615 (US)

(72)	Inventor:
	EARLY, Ryanne Fleming Island, FL 32003 (US)

(74)	Representative: Potter Clarkson
	The Belgrave Centre Talbot Street Nottingham NG1 5GG Nottingham NG1 5GG (GB)

(56)

References cited: :

WO-A2-03/082201
WO-A2-2007/124127

WO-A2-2005/009498

Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).